UK markets closed

Regulus Therapeutics Inc. (RGLS)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.6750+0.1650 (+6.57%)
As of 02:56PM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts4443
Avg. Estimate-0.22-0.11-0.51-0.61
Low estimate-0.44-0.13-0.57-0.75
High estimate-0.11-0.1-0.42-0.47
Year ago EPS-0.42-0.37-1.58-0.51
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts3343
Avg. EstimateN/AN/AN/AN/A
Low estimateN/AN/AN/AN/A
High estimateN/AN/AN/AN/A
Year ago salesN/AN/AN/AN/A
Sales growth (year/est)N/AN/AN/AN/A
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.44-0.41-0.4-0.39
Actual EPS-0.42-0.37-0.4-0.4
Difference0.020.040-0.01
Surprise %4.50%9.80%0.00%-2.60%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.22-0.11-0.51-0.61
7 days ago-0.22-0.11-0.51-0.61
30 days ago-0.22-0.11-0.51-0.61
60 days ago-0.39-0.43-1.59-1.19
90 days ago-0.39-0.43-1.59-1.19
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesRGLSIndustrySector(s)S&P 500
Current qtr.47.60%N/AN/AN/A
Next qtr.70.30%N/AN/AN/A
Current year67.70%N/AN/AN/A
Next year-19.60%N/AN/AN/A
Next 5 years (per annum)39.60%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A